An imaging technique identified emerging drugs that activate the STING protein to alter metabolic pathway activity in cancer cells.
List view / Grid view
Sphingosine-1 phosphate was found to regulate blood glow in cerebral blood vessels in mice, presenting a potential therapeutic target.
Researchers have developed an inexpensive method for visualising blood flow in the brain that can discern the motions of individual blood cells.
Evaluation of neurotoxicity effects is an active area of investigation in drug discovery and disease modeling.
The cell painting assay uses up to six fluorescent dyes to label and visualize a variety of subcellular structures at the single cell level.
In this exclusive report, find an in-depth analysis of AI and informatics within imaging, synthetic biology, drug screening and drug design. Featured interviews with experts from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.
In this interview, read about the compilation of a new high-resolution cell atlas of the mouse brain using spatial genomics and transcriptomics.
Depletion of ATP due to viral-induced CPE leads to a reduction in luminescence signal, enabling quantitation of viral-induced CPE in host cells.
A non-invasive, label-free optical method can produce high-resolution imaging of cellular brain diseases in vivo.
A US team has designed a high-quality, high-speed imaging system that could lead to new understandings of complex tissue specimens.
Scientists have presented a new method for generating the metabolic profiles of cells which could answer questions on conditions such as cancer and liver disease.
Researchers at UT Southwestern have invented a novel microscopy method that could open new avenues of advanced microscopy.